Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP)

Historical Holders from Q4 2024 to Q3 2025

Symbol
CAMP on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
52,122,667
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
28,210,083
Holdings value
$84,630,390
% of all portfolios
0.001%
Number of holders
28
Number of buys
13
Number of sells
-16
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
5AM Ventures VI, L.P. 12.5% $8,392,800 5,869,091 Andrew J. Schwab 09 Sep 2025
Coastlands Capital LP 9.99% $21,452,710 4,886,722 Coastlands Capital LP 10 Sep 2025
Polaris Management Co. VII, L.L.C. 8.4% $5,623,119 3,932,251 Amir Nashat 09 Sep 2025
Vivo Opportunity Fund Holdings, L.P. 7.6% $5,485,161 3,561,793 Vivo Opportunity Fund Holdings, L.P. 11 Sep 2025
FMR LLC 6.7% -55.3% $9,436,989 +$366,687 3,145,663 +4% FMR LLC 31 Oct 2025
Enavate Sciences GP, LLC 6% -26.2% $13,729,110 -$2,890,560 3,127,360 -17.4% Enavate Sciences GP, LLC 19 Dec 2025
Northpond Ventures II, LP 4.8% $6,714,732 2,238,244 Michael P. Rubin 30 Sep 2025
AH Bio Fund I, L.P. 4.5% $6,376,017 2,125,339 Marc L. Andreessen 30 Sep 2025
HARBOURVEST PARTNERS LLC 2.7% -60% $3,536,015 1,271,948 0% HarbourVest Partners L.P. 30 Sep 2025

Institutional Holders of Camp4 Therapeutics Corp - Common Stock, $0.0001 par value per share (CAMP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 28,210,083 $84,630,390 +$49,505,803 $3 28
2025 Q2 11,744,129 $17,029,220 -$3,217,598 $1.45 28
2025 Q1 12,677,488 $50,710,355 -$1,002,366 $4 39
2024 Q4 12,854,057 $67,096,861 +$47,332,167 $5.22 36